3 recruiting. 3 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 3 | Recruiting 3 |
Follow Bronchiolitis: new trials by email Literature Review of Bronchiolitis trials Research Report on Bronchiolitis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Anrikefon vs Nalfurafine for Sleep Quality in Hemodialysis Patients With CKD-aP Anrikefon, Nalfurafine - Pruritus Chronic, Kidney Diseases, Chronic | Phase 4 | Recruiting | Zhujiang Hospital | 50 | 2026-06-22 | 2026-08-25 |
| Pegmolesatide Treatment for Anemia in Patients Undergoing Long-term Dialysis The rHuEPO Monotherapy Group (Control Group), The Pegmolesatide and Roxadustat Combination Therapy Group (Exploratory Group), The Pegmolesatide Monotherapy Group (Experimental group) - Dialysis; Complications, Chronic Kidney Disease 5D | Phase 4 | Recruiting | Chinese PLA General Hospital | 240 | 2025-08-01 | 2025-09-12 |
| Efficacy of Lavender Essential Oil Chest Wraps in Infants With Bronchiolitis Lavender essential oil 10%, diluted in 90% olive oil, Control - Bronchiolitis | Phase 4 | Recruiting | University Hospital, Geneva | 400 | 2023-12-07 | 2025-03-30 |
Bronchiolitis Obliterans Syndrome (2) · Cough (1) · Renal Insufficiency, Chronic (1) · Uremia (1)
Bronchial Diseases (3) · Bronchitis (3) · Lung Diseases (3) · Lung Diseases, Obstructive (3) · Respiratory Tract Diseases (3) · Bronchiolitis Obliterans (2) · Graft vs Host Disease (2) · Immune System Diseases (2) · Organizing Pneumonia (2) · Pathological Conditions, Signs and Symptoms (2) · Chronic Disease (1) · Disease Attributes (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1)
Control Groups (1) · Olive Oil (1) · TRK 820 (1) · lavender oil (1)
Chinese PLA General Hospital (1) · University Hospital, Geneva (1) · Zhujiang Hospital (1)
China (2) · Switzerland (1)
Klara Posfay-Barbe, MD, PhD (1) · Xiangmei Chen (1)